Risk Factors for Severe Complications in Ovarian Cancer Surgery.
Ovarian cancer
Postoperative period
postoperative complications
surgical oncology
Journal
In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809
Informations de publication
Date de publication:
Historique:
received:
08
09
2020
revised:
17
09
2020
accepted:
21
09
2020
entrez:
4
11
2020
pubmed:
5
11
2020
medline:
22
6
2021
Statut:
ppublish
Résumé
Backround: Due to extensive surgical intervention for macroscopic complete cytoreduction in epithelial ovarian cancer (EOC) patients, severe complications in the postoperative course are possible. A total of 345 EOC patients who underwent cytoreductive surgery were retrospectively evaluated regarding risk factors for an unfavorable postoperative course. Possible pre-, intra- and postoperative risk factors were statistically analyzed performing multivariate ordinal logistic regression. A total of 345 EOC patients underwent cytoreductive surgery. There were no complications in 114 patients, mild complications in 114 patients and severe complications in 117 patients. The risk factor evaluation identified age (p=0.049), smoking (p=0.032) and duration of surgery (p<0.0001) as significant factors for severe postoperative morbidity. In EOC patients age, smoking and the duration of surgery have significant impact on the postoperative course. Only the duration of surgery can be positively influenced by a well-trained EOC team.
Identifiants
pubmed: 33144443
pii: 34/6/3361
doi: 10.21873/invivo.12174
pmc: PMC7811609
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3361-3365Informations de copyright
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Références
Surg Endosc. 2011 Jul;25(7):2288-95
pubmed: 21298533
BJOG. 2016 Jan;123(2):300-8
pubmed: 26331299
Br J Cancer. 2015 Sep 1;113(5):817-26
pubmed: 26151456
Anticancer Res. 2019 Sep;39(9):5209-5218
pubmed: 31519635
Gynecol Oncol. 2017 Sep;146(3):498-503
pubmed: 28610745
Arch Surg. 2001 Apr;136(4):405-11
pubmed: 11296110
Am J Obstet Gynecol. 2019 Jun;220(6):571.e1-571.e8
pubmed: 30771346
Gynecol Oncol. 2009 Dec;115(3):334-8
pubmed: 19766295
Gynecol Oncol. 2011 Nov;123(2):187-91
pubmed: 21794902
Gynecol Oncol. 2014 Oct;135(1):19-24
pubmed: 25110330
Anesthesiology. 2011 Apr;114(4):837-46
pubmed: 21372682
Surg Clin North Am. 1994 Feb;74(1):23-39
pubmed: 8108769
Am J Obstet Gynecol. 2007 Dec;197(6):676.e1-7
pubmed: 18060979
J Am Coll Surg. 2015 Apr;220(4):550-8
pubmed: 25728140
Int J Gynecol Cancer. 2015 Jan;25(1):135-44
pubmed: 25423317
Ann Surg Oncol. 2010 May;17(5):1291-301
pubmed: 20039212
Ann Surg. 2014 Jan;259(1):52-71
pubmed: 23799418
J Am Coll Surg. 2006 Dec;203(6):865-77
pubmed: 17116555
J Vasc Surg. 2016 Mar;63(3):730-6
pubmed: 26553950
Eur J Anaesthesiol. 2011 Jan;28(1):10-5
pubmed: 21166109
Ann Surg Oncol. 2015 Apr;22(4):1061-7
pubmed: 25319579